Please assess the completion status of the following clinical trial:

Trial Title: A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Female patient, 18 years of age or older diagnosed with an ovarian adnexal mass, or in follow-up due to the presence of BRCA1/2 and other germline DNA variants.~* Patient reviewed, understood, and provided the PI with written informed consent to allow blood specimen to be used for research and release of medical information.~Exclusion Criteria:~* Patient is less than 18 years of age~* Patient is not being treated in the U.S.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (Type: None): Symptomatic with adnexal mass
- Group B (Type: None): Asymptomatic with adnexal mass
- Group C (Type: None): Women with a predisposition in developing ovarian cancer due to a positive, pathogenic variant

Based on this trial design, predict the completion outcome and termination type (if applicable).